Bibliografía.

1. Corwin HL, Gettinger A, Levy MM. The CRIT study: anemia and blood transfusion in the critically ill. Current clinical practice in the United States. Crit Care Med 2004; 32 (1):39-52.
2. Rudis M, Jacobi J, Hassan E. Managing Anemia in the Critically Ill Patient. Pharmacotherapy 2004; 24 (2):229-247.
3. Polonen P, Ruokonen E, Hippelaine M. A prospective ramdomized study of goal oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 2000; 90:1052-9.
4. Gattinoni L, Brazzi L, Pelosi P. A trial of goal oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333:1025-32.
5. Choi PT, Yip G. Cristalloids vs coloids in fluid resucitation: a systematic review. Crit Care Med 1999; 27:200-10.
6. Schierhout G, Robert I. Fluid resuscitation with coloids or cristalloids in critically ill patients: a systematic review of ramdomized trials. BMJ 1998; 316:961-4.
7. Rizoli SB. Crystaloids and coloids in trauma resuscitation: a brief overview of the current debate. J Trauma 2003; 54 (5):82-8.
8. Mollison PL, Engelfriet CP, Contreras M, Editores. Blood transfusion in clinical medicine10th ed. London: Blackwell Science LTD; 1997.
9. Contreras M. Editora. ABC of transfusion. 3rd ed. BMJ Books. Bristol K; 1998.
10. Cheatham ML, Block FJ, Nelson LD. Shock: an overview. En Intensive Care Medicine. Raven: Lippincott; 1999. p. 1961-79.
11. Gilham MJ, Parr MJ. Resuscitation for major trauma. Curr opin Anaesthesiology 2002; 15: 167-172.
12. Wilkes NJ, Woolf R, Mutch M. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93 (4):811-6.
13. Kramer GC. Hypertonic resuscitation: Physiologic mechanims and recommendations for trauma care. J Trauma 2003; 54: 89-99.
14. Biancaniello PL, Kim AJ, Crocker JC. Colloidal interactions. Phys Rev 2005; 94 (5):583-89.
15. McGee S, Abernethy WB, Simel DL. Is this patient hypovolemic? JAMA 1999; 281:1022-29.
16. Onen A, Cigdem MK, Deveci E, Kaya S. Effects of whole blood, crystalloid, and colloid resuscitation of hemorrhagic shock on renal damage in rats: an ultrastructural study. J Pediatr Surg 2003; 38 (11):1642-9.
17. Leynadier F, Wessel F. Skin tests for diagnosis of hypersensitivity to colloidal plasma substitutes. Ann Fr Anesth Reanim 2002; 21:121-122.
18. Bulanov AIu, Gorodetskii VM, Shulutko EM. Effect of different colloid volume-replacing solutions on a changed hemostasis system. Anesteziol Reanimatol 2004; 2:25-30.
19. Roberts I, Edwards P, McLelland B: More on albumin: use of human albumin in UK. BMJ 1999; 328:211-14.
20. Watanabe K. Plasma osmotic pressure and oncotic pressure. Nippon Rinsho 2005; 63 (1):26-30.
21. Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004; 72:2029-32.
22. Finfer S, Bellomo R, Boyce N. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 371 (2): 2247-50.
23. Celik I, Duda D. Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings. Inflamm Res 2003; 52 (10):408-16.
24. Rabanal JM, Mons R, Seco I, Calvo R, Quesada A. Estudio comparativo de la eficacia resucitadora de Ringer lactato, gelatinas y solución salina hipertónica al 2% en un modelo experimental canino de hemorragia aguda. Rev Cirugía Esp 2000; 24 (9):398-404.
25. Ickx BE, Bepperling F, Melor C, Schulman C, Van der Linden PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth2003; 91: 196-202.
26. Muir WW, Wiese AJ. Comparison of lactated Ringer's solution and a physiologically balanced 6% hetastarch plasma expander for the treatment of hypotension induced via blood withdrawal in isoflurane-anesthetized dogs. Am J Vet Res 2000; 65 (9):1189-94.
27. Boldt J. Limited Dosage for HES? Anasthesiol Intensivmed Notfallmed Schmerzther 2001; Suppl 2:S102-3.
28. Ebo DG, Schuerwegh A, Stevens WJ. Anaphylaxis to starch. Allergy 2000; 55 (11):1098-9.
29. Jonville-Bera AP, Autret-Leca E, Gruel Y. Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch. N Engl J Med 2001; 345 (8):622-3.
30. Lieberthal W, Fuhro R, Alam H, Rhee P. Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions. Shock 2002; 17 (1):61-9.
31. Alexander JC. Hetastarch in perioperative volume expansion. Chest 2003; 124 (4):1194-6.
32. De Labarthe A, Jacobs F, Blot F, Glotz D. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 2001; 111 (5):417-8.
33. Waters JH, Bernstein CA. Dilutional acidosis following hetastarch or albumin in healthy volunteers. Anesthesiology 2000; 93 (5):1184-7.
34. Bouchut JC, Lepape A, Carry PY. Effects of hydroxyethylstarch infusion on drug protein binding in critically ill patients. Eur J Anaesthesiol 2001; 18 (8):558-9.
35. Haynes GR, Bailey MK. Excessive use of hetastarch: An iatrogenic cause of bleeding and hypocalcemia? Anesth Analg 2000; 90 (6):1455-6.